Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Using Mesh for Hernia Repair Shows Mixed Results

By HospiMedica International staff writers
Posted on 04 Nov 2016
Although mesh reinforcement for hernia repair is associated with several benefits, these are offset by mesh-related complications, claims a new study.

Researchers at Hvidovre Hospital (Denmark) and Zealand University Hospital (Køge, Denmark) conducted a study that included 3,242 patients (average age 59; 53% women), who underwent elective incisional hernia repairs in Denmark from January 2007 to December 2010. More...
Among these, 35% underwent open mesh repair, 11% had open non-mesh repair, and 54% had laparoscopic mesh repair. Median follow-up for all procedures was about five years.

The results showed that the risk of subsequent recurrent hernia was lower for patients with open mesh repair (12%) and for patients with laparoscopic mesh repair (10.6%), than for those who had non-mesh repair (17.1%). A progressively increasing number of mesh-related complications, including bleeding, bowel obstruction, bowel perforation, and late abscess, were also noted. At five years of follow-up, the cumulative incidence of mesh-related complications was 5.6% for patients who underwent open mesh hernia repair and 3.7% for patients who underwent laparoscopic mesh repair.

Conversely, the long-term repair-related complication rate for patients with an initial non-mesh repair was 0.8%. The researchers commented, however, that larger, more complicated hernias are likely to be repaired with mesh, while small, simple hernias with little likelihood of long-term problems tend to be repaired without mesh. The study was presented at the American College of Surgeons (ACS) clinical congress, held during October 2016 in Washington (DC, USA).

“Mesh implantation prevented the need for subsequent reoperation in relatively few patients, suggesting that the benefits associated with the use of mesh are partially off¬set by long-term complications associated with its use,” concluded senior author Thue Bisgaard, MD, PhD, of Hvidovre Hospital, and colleagues. “The complete spectrum for the risks and benefits of mesh used to reinforce hernia repair is not known, because there are very few clinical trial data reporting hernia outcomes as they pertain to mesh utilization.”

Related Links:
Hvidovre Hospital
Zealand University Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.